Trending
April 14, 2025 Viatris Appoints Hemanth J. Varghese as Chief Strategy OfficerApril 14, 2025 CytoSorbents Appoints Thomas Shannon as Vice President of Marketing for North AmericaApril 14, 2025 S&P Global and CME Group To Sell OSTTRA To KKR For $3.1 BillionApril 14, 2025 R.J. O’Brien to be Acquired by StoneX GroupApril 14, 2025 Ronin Equity Partners and Landon Capital Partners Sell Heartisan Foods to The Gellert Global Group
April 14, 2025 Viatris Appoints Hemanth J. Varghese as Chief Strategy OfficerApril 14, 2025 CytoSorbents Appoints Thomas Shannon as Vice President of Marketing for North AmericaApril 14, 2025 S&P Global and CME Group To Sell OSTTRA To KKR For $3.1 BillionApril 14, 2025 R.J. O’Brien to be Acquired by StoneX GroupApril 14, 2025 Ronin Equity Partners and Landon Capital Partners Sell Heartisan Foods to The Gellert Global Group
Featured
April 14, 2025
Viatris Appoints Hemanth J. Varghese as Chief Strategy Officer
Viatris Inc. (Nasdaq: VTRS) today announced that Hemanth J. Varghese has joined the Company as Chief Strategy... Read more »
April 14, 2025
CytoSorbents Appoints Thomas Shannon as Vice President of Marketing for North America
CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive... Read more »
April 14, 2025
S&P Global and CME Group To Sell OSTTRA To KKR For $3.1 Billion
S&P Global and CME Group today announced the signing of a definitive agreement to sell OSTTRA, a leading provider... Read more »
